GSK plc Files Form 6-K: PDMR Transaction Notification
Ticker: GLAXF · Form: 6-K · Filed: Sep 4, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Sep 4, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, disclosure, PDMR
TL;DR
GSK plc filed a 6-K for a PDMR transaction notification from SVP & Company Secretary Victoria Whyte.
AI Summary
On September 4, 2025, GSK plc filed a Form 6-K reporting a transaction notification from Victoria Whyte, SVP & Company Secretary. This initial notification details a PDMR/person closely associated with them.
Why It Matters
This filing provides transparency regarding director and senior manager dealings in company shares, which can influence investor perception of insider confidence.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of director/PDMR shareholding information, not indicating any significant operational or financial risk.
Key Players & Entities
- GSK plc (company) — Registrant
- Victoria Whyte (person) — SVP & Company Secretary
- 001-15170 (company) — SEC File Number
- 79 New Oxford Street, London, WC1A 1DG (company) — Principal executive office address
FAQ
What type of transaction is being reported by Victoria Whyte?
The filing indicates an 'Initial notification' for a PDMR/person closely associated with them, but the specific transaction details are not fully provided in the excerpt.
What is Victoria Whyte's role at GSK plc?
Victoria Whyte holds the position of SVP & Company Secretary at GSK plc.
What is the filing date of this Form 6-K?
The filing date is September 4, 2025.
What is the SEC file number for GSK plc?
The SEC file number for GSK plc is 001-15170.
Does GSK plc file annual reports under Form 20-F or 40-F?
GSK plc indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 361 words · 1 min read · ~1 pages · Grade level 14.8 · Accepted 2025-09-04 11:36:09
Filing Documents
- a0502y.htm (6-K) — 31KB
- 0001654954-25-010402.txt ( ) — 32KB
SIGNATURES
SIGNATURES     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.   GSK plc   (Registrant)     Date: September 04, 2025         By:/s/ VICTORIA WHYTE --------------------------       Victoria Whyte   Authorised Signatory for and on   behalf of GSK plc